Circassia Pharmaceuticals (GB:NIOX) has released an update.
Circassia Pharmaceuticals’ NIOX Group PLC is enhancing its leadership team by appointing Robert Naylor as Non-Executive Director and Chair of the Audit and Risk Committee. Naylor comes with over 25 years of experience in the healthcare capital markets and holds significant roles in various investment companies. The company anticipates that his extensive business and corporate development expertise will be pivotal in advancing their global leadership in asthma diagnosis and management.
For further insights into GB:NIOX stock, check out TipRanks’ Stock Analysis page.
